A recent study, based on a modest number of CKD patients, has interestingly proposed to use the inflammation-based modified Glasgow prognostic score (mGPS) [19] in CKD management, given by the combination of C reactive protein (CRP) values with albumin levels. The gene discussed is ALB; the disease is chronic kidney disease.